CareFusion 303, Inc.

The case before the court involved CareFusion 303, Inc., which was contesting an examiner’s objection to its patent application. The dispute centred on whether the claimed system for managing the retrieval of prepared medications constituted a "manner of manufacture" as required by the relevant legislation, or if it was merely a scheme or business method which would not be patentable. The case was heard in the Federal Court of Australia.

The primary legal issue the court had to resolve was whether the amendments made to the patent application following an adverse decision by a hearing officer sufficiently aligned the claimed system with the statutory requirement of being a "manner of manufacture". Specifically, the court needed to determine if the system described in the amended claims was a tangible invention linked to a practical utility, or if it was merely an abstract idea or scheme without any practical application.

The court examined the nature of the invention and whether it was a mere scheme or business method, as opposed to a tangible manner of manufacture. It considered the essence of the invention, focusing on the combination of hardware and software components, and whether the practical and useful effect of the invention arose from the ingenuity of the inventors. The court noted that while the claims included both hardware and software, the patentability did not depend on the presence or absence of hardware but rather on the substantive invention itself. The court concluded that the claimed system, despite its broad and abstract nature, constituted a manner of manufacture as it involved a series of steps and intercommunicating components leading to a concrete effect.

Ultimately, the court ruled in favour of CareFusion 303, Inc., finding that the amended claims did indeed define a manner of manufacture and were therefore patentable. The court's decision hinged on the interpretation of the statutory requirement and the practical utility of the invention as described in the amended claims.